RxDoctor Payments Data

Barbara Pittman

Family · Waycross, GANPI 1003208497

Payments from drug & device makers

$8,558in general payments, 2019–2025

Across 440 payments — averaging $19.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • AbbVie$1K
  • Johnson & Johnson$1K
  • UCB, Inc.$1K
  • Novartis$448
  • Mallinckrodt Hospital Products Inc.$395
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$8,34497%
  • Education$2143%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,558 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$64,636
Medicare patients
198
Services billed
1,226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydroxychloroquine Sulfate594$17,774
Leflunomide170$6,324
SavellaMilnacipran Hcl12$5,522
Gabapentin307$4,075
Pilocarpine Hcl53$3,200
Duloxetine Hcl163$2,558
Tramadol Hcl274$2,496
Mycophenolate Mofetil27$2,223
Diclofenac Sodium41$2,105
MethotrexateMethotrexate Sodium126$1,875
Tizanidine Hcl207$1,769
Sulfasalazine58$1,597
Colchicine19$1,137
Allopurinol153$1,061
Baclofen69$1,041

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSavella$1,485$5,52212 claims
Scilex Pharmaceuticals Inc.Colchicine$43$1,13719 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,258 family providers in Georgia.

Other family in Waycross

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →